Oct 24, 2022 / 08:30PM GMT
Suzanne Winter - Accuray Incorporated - President, CEO & Director
Everyone who's on Zoom as well and joining this session. We have a very rich agenda today where we're going to hear from key opinion leaders -- hi, Marie, who will be talking a little bit about innovation and the future of radiation therapy over the coming years.
So you can see from the agenda overall, we're going to start out with Dr. Jean-Philippe Pignol, who's our Global Chief Medical Officer, Chief Technology Officer. He'll be talking a little bit about clinical evidence. And then we're going to go into 3 different care areas and prostate breast and neurological indications.
For prostate, we have Dr. Peter Orio, who's here with us. He's the Vice Chair of Radiation Oncology for Dana-Farber at Brigham and Women's. We also have Matthew Witten. He's our Chief Physicist, Department of Radiation Oncology and Director of the CyberKnife Radiosurgery at NYU Langone. Then when we're talking about breast, we have Frank Vicini, who's the National Principal Investigator at GenesisCare Oncology, as well as Brian Collins,
Accuray Inc At ASTRO Transcript
Oct 25, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers